Amplia Therapeutics Limited (INNMF)
USD 0.06
(0.0%)
USD 0.06
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | - | 1.18 Million | 1.98 Million | 1.53 Million | 34.22 Thousand | - |
| Cost of Revenue | 86.14 Thousand | 73.36 Thousand | 3209.00 | 672.00 | 801.00 | 1590.00 |
| Gross Profit | -86.14 Thousand | 1.11 Million | 1.98 Million | 1.53 Million | 33.42 Thousand | -1590.00 |
| Operating Expenses | 8.93 Million | 7.47 Million | 5.62 Million | 3.87 Million | 2.25 Million | 1.94 Million |
| Selling, General and Administrative Expenses | 3.13 Million | 2.4 Million | 1.69 Million | 1.34 Million | 1.06 Million | 1.04 Million |
| Research and Development Expenses | 5.8 Million | 4.68 Million | 3.77 Million | 2.21 Million | 1.07 Million | 736 Thousand |
| Other Expenses | - | 1.18 Million | 1.98 Million | 1.59 Million | 34 Thousand | 51 Thousand |
| Cost and Expenses | 9.02 Million | 7.47 Million | 5.62 Million | 3.87 Million | 2.25 Million | 1.94 Million |
| Operating Income | -9.02 Million | -6.18 Million | -3.64 Million | -3.87 Million | -2.25 Million | -1.94 Million |
| Interest Expense | 78.48 Thousand | 53.84 Thousand | 1150.00 | - | - | - |
| Income Tax Expense | -4.43 Million | 1.24 Million | 1.98 Million | -1000.00 | -4000.00 | -20 Thousand |
| Earnings before Tax | -8.94 Million | -6.24 Million | -3.64 Million | -2.28 Million | -2.21 Million | -1.87 Million |
| Net Income | -4.5 Million | -6.24 Million | -3.64 Million | -2.28 Million | -2.21 Million | -1.87 Million |
| Earnings Per Share Basic | -0.02 | -0.03 | -0.02 | -0.02 | -0.04 | -0.04 |
| Earnings Per Share Diluted | -0.02 | -0.03 | -0.02 | -0.02 | -0.04 | -0.04 |
| Weighted Average Shares Outstanding | 199.61 Million | 193.97 Million | 145.54 Million | 95.7 Million | 52.95 Million | 43.43 Million |
| Weighted Average Shares Outstanding (Diluted) | 199.61 Million | 193.97 Million | 145.54 Million | 95.7 Million | 52.95 Million | 43.43 Million |
| Gross Margin | - | 0.94 | 1.00 | 1.00 | 0.98 | - |
| EBIT Margin | - | -5.14 | -1.84 | -2.53 | -65.91 | - |
| Profit Margin | - | -5.25 | -1.84 | -1.49 | -64.83 | - |
| EBITDA | -8.93 Million | -6.11 Million | -3.63 Million | -3.87 Million | -2.25 Million | -1.93 Million |
| Earnings Before Tax Margin | - | -5.20 | -1.84 | -2.53 | -65.94 | - |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 1.22 Million | 1.22 Million | 1.18 Million | -289.94 Thousand |
| Cost of Revenue | 43.2 Thousand | 86.14 Thousand | 42.94 Thousand | 55.7 Thousand | 73.36 Thousand | 44.37 Thousand |
| Gross Profit | -43.2 Thousand | -86.14 Thousand | 1.18 Million | 1.16 Million | 1.11 Million | -334.32 Thousand |
| Operating Expenses | 5.37 Million | 8.93 Million | 3.56 Million | 1.74 Million | 7.47 Million | 2.75 Million |
| Selling, General and Administrative Expenses | 1.75 Million | - | 1.37 Million | 630.7 Thousand | - | 1.59 Million |
| Research and Development Expenses | 3.61 Million | - | 2.19 Million | 1.09 Million | - | 1.15 Million |
| Other Expenses | - | - | - | - | 1.18 Million | - |
| Cost and Expenses | 5.41 Million | 9.02 Million | 3.6 Million | 1.8 Million | 7.47 Million | 2.79 Million |
| Operating Income | -5.41 Million | -9.02 Million | -3.6 Million | -580.58 Thousand | -6.18 Million | -2.79 Million |
| Interest Expense | 31.84 Thousand | 78.48 Thousand | 46.63 Thousand | - | 53.84 Thousand | 37.7 Thousand |
| Income Tax Expense | -1.98 Million | -4.43 Million | -2.44 Million | -21.8 Thousand | 1.24 Million | 579.89 Thousand |
| Earnings before Tax | -5.36 Million | -8.94 Million | -3.57 Million | -564.62 Thousand | -6.24 Million | -2.75 Million |
| Net Income | -3.37 Million | -4.5 Million | -1.12 Million | -564.62 Thousand | -6.24 Million | -3.33 Million |
| Earnings Per Share Basic | -0.02 | - | -0.01 | -0.00 | - | -0.02 |
| Earnings Per Share Diluted | -0.02 | - | -0.01 | -0.00 | - | -0.02 |
| Weighted Average Shares Outstanding | 199.61 Million | 199.61 Million | 199.61 Million | 194.02 Million | 193.97 Million | 199.61 Million |
| Weighted Average Shares Outstanding (Diluted) | 199.61 Million | 199.61 Million | 199.61 Million | 194 Million | 193.97 Million | 199.61 Million |
| Gross Margin | - | - | 0.96 | 0.95 | 0.94 | 1.15 |
| EBIT Margin | - | - | -2.91 | -0.46 | - | 9.49 |
| Profit Margin | - | - | -0.92 | -0.46 | -5.25 | 11.49 |
| EBITDA | -5.37 Million | - | -3.56 Million | -559.1 Thousand | - | -2.75 Million |
| Earnings Before Tax Margin | - | - | -2.95 | -0.47 | -5.20 | 9.64 |
ACE
GPIL
NANOFH
IDCBF
SEOJF
600336